Search by Drug Name or NDC

    NDC 50742-0299-09 FROVATRIPTAN 2.5 mg/1 Details

    FROVATRIPTAN 2.5 mg/1

    FROVATRIPTAN is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ingenus Pharmaceuticals, LLC. The primary component is FROVATRIPTAN SUCCINATE.

    Product Information

    NDC 50742-0299
    Product ID 50742-299_e6dff149-d47e-4c5d-b5a1-b7d14583bc54
    Associated GPIs
    GCN Sequence Number 048986
    GCN Sequence Number Description frovatriptan succinate TABLET 2.5 MG ORAL
    HIC3 H3F
    HIC3 Description ANTIMIGRAINE PREPARATIONS
    GCN 14977
    HICL Sequence Number 022988
    HICL Sequence Number Description FROVATRIPTAN SUCCINATE
    Brand/Generic Generic
    Proprietary Name FROVATRIPTAN
    Proprietary Name Suffix n/a
    Non-Proprietary Name frovatriptan succinate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name FROVATRIPTAN SUCCINATE
    Labeler Name Ingenus Pharmaceuticals, LLC
    Pharmaceutical Class Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213891
    Listing Certified Through 2024-12-31

    Package

    NDC 50742-0299-09 (50742029909)

    NDC Package Code 50742-299-09
    Billing NDC 50742029909
    Package 1 BLISTER PACK in 1 CARTON (50742-299-09) / 9 TABLET, FILM COATED in 1 BLISTER PACK
    Marketing Start Date 2022-07-22
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 6.02896
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description FROVATRIPTAN SUCC 2.5 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis